GainersToday.com
GainersToday.com, Tracking Stock Market Picks
Enter Symbol:
 
MEDIVATION INC (MDVN) [hlAlert]

Medivation, Inc. is a biopharmaceutical company with small molecule drugs in clinical development to treat three medical needs: Alzheimer?s disease,
Huntington?s disease and castration-resistant prostate cancer. The Company has formed separate subsidiaries to hold the product candidates it is developing. The Company?s subsidiary Medivation Neurology, Inc. holds its Dimebon technology, and its subsidiary Medivation Prostate Therapeutics, Inc. holds its MDV300 series technology.
.
( Total: 25 Current Stock Recommendations )
MEDIVATION INC   (25)
Sell Hold 28% Buy 68%
Related companies
China Biologic ...   (4)
Buy 100%
Opko Health Inc   (2)
Buy 100%
Talecris ...   (4)
Buy 100%
Anacor ...   (6)
Buy 100%
Santarus, Inc.   (13)
Hold 31% Buy 69%
Cardinal Health, ...   (24)
Hold 29% Buy 71%
Incyte Corporation   (22)
Sell Hold Buy 82%
Nbty, Inc.   (9)
Hold 44% Buy 56%
Dr. Reddy's ...   (5)
Sell 20% Hold 40% Buy 40%
Salix ...   (31)
Hold 39% Buy 61%
Show  

Date (ET)MemberRatingYTD
Gains
 
10/31/2007  
Buy
  
1/29/2008  
Buy
  
3/17/2009  
Buy
  
3/3/2010  
Hold
  
3/4/2010  
Hold
  
4/26/2010  
Buy
  
9/7/2011  
Buy
  
9/16/2011  
Buy
  
11/10/2011  
Sell
  
1/23/2012  
Buy
  
9/4/2012  
Buy
  
3/28/2013  
Buy
  
5/7/2013  
Buy
  
1/28/2014  
Buy
  
1/29/2014  
Buy
  
1/29/2014  
Buy
  
2/3/2014  
Buy
  
2/3/2014  
Hold
  
2/3/2014  
Hold
  
2/28/2014  
Hold
  
1/29/2015  
Buy
  
8/25/2015  
Buy
  
9/28/2015  
Buy
  
11/6/2015  
Hold
  
1/27/2016  
Hold
  

* As of 8/27/2015 12:00 AM
RSS Feed | |  Facebook |  Twitter |  Google Plus
Home | Terms of Use | Advertise | FAQ | Support Page | Contact Us | About Us | Privacy Policy